This interaction increases the risk of side effects like tremors, high blood pressure, and kidney toxicity
Despite their clinical effectiveness and the volume they represent in the market, real-world use of GLP-1s is heavily influenced by non-clinical factors such as drug availability, insurance coverage, and formulary decisions ( 5 , 6 )
Zepbound leads on reality: it is FDA-approved, prescribable, and available right now, while retatrutide remains in Phase 3 and cannot be legally filled for weight loss as of June 2026
1 Do Yoga Got some trapped gas that youre struggling to relieve
doi: 10.1016/S0304-3940(01)01618-4 191 PerryTHaugheyNJMattsonMPEganJMGreigNH
b The drugs were developed, initially to address, obesity and diabetes, and thats a huge market